Format

Send to

Choose Destination
Urol Clin North Am. 2015 Nov;42(4):493-505. doi: 10.1016/j.ucl.2015.05.005. Epub 2015 Jul 15.

Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.

Author information

1
Division of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 900, Chicago, IL 60611, USA. Electronic address: daniel.boyle@northwestern.edu.
2
Division of Infectious Diseases, Department of Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 900, Chicago, IL 60611, USA.

Abstract

Worldwide prevalence of antimicrobial resistance is rapidly increasing, primarily a result of antibiotic misuse in the medical community. Resistant infections involving the urinary tract are typically caused by gram-negative bacteria. When treating these infections, clinicians have few effective antimicrobials to choose from and many are associated with significant adverse effects. There are now situations when clinicians are tasked with managing infections from pan-resistant organisms; thus, it is of paramount importance that spread of resistance be controlled. This review discusses common gram-negative resistance classes, highlighting the mechanisms of resistance, risk factors, type of infections, treatment, and outcomes associated with each class.

KEYWORDS:

Antibiotic resistance; Carbapenem-resistant Acinetobacter baumannii; Carbapenem-resistant enterobacteriaceae; Extended-spectrum β-lactamases; Multidrug-resistant Pseudomonas aeruginosa; New Delhi metallo–β-lactamase

PMID:
26475946
DOI:
10.1016/j.ucl.2015.05.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center